---
created: 2025-04-13
updated: 2025-04-13T10:51
id: t=J)JQ,UQq
specialty: nephro
specialty_id: 69
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::19-renal::02-acid-base::04-metabolic-alkalosis
  - source/ak-step1-v11::
  - theme/b&b::19-renal::05-other::03-diuretics
  - source/ak-step1-v11::
  - theme/firstaid::14-renal::05-pharm::03-acetazolamide
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::12-renal
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::06-renal::02-acetazolamide
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::17-renal::acetazolamide
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::02-diuretics::01-acetazolamide,-mannitol
  - source/ak-step1-v11::
  - theme/uworld::10000-99999::18000-18999::18937
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::renal::pharmacology"
type: flashcard
---

# Question
What acid-base disorder may be treated with acetazolamide?    **Metabolic alkalosis**

---

# Answer
Carbonic anhydrase inhibitors = inhibit the reabsorption of sodium bicarbonate (NaHCO3) *proximal tubule* == increased HCO3âˆ’ excretion. The metabolic acidosis generated reduces blood alkalinity == normalizing pH